Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study
Paul G. Richardson, Sara Bringhen, Peter M. Voorhees, Torben Plesner, Ulf‐Henrik Mellqvist, Brandi Reeves, Claudia E. Paba‐Prada, Hanan Zubair, Catriona Byrne, Dharminder Chauhan, Kenneth C. Anderson, Eva Nordström, Johan Harmenberg, Antonio Palumbo, Pieter Sonneveld
Topics & Concepts
MedicineOpen labelDexamethasoneMultiple myelomaRefractory (planetary science)Internal medicineOncologyPhases of clinical researchClinical trialPhysicsAstrobiologyMultiple Myeloma Research and TreatmentsPI3K/AKT/mTOR signaling in cancerCancer, Stress, Anesthesia, and Immune Response